Personal information

Activities

Employment (2)

The Second Affiliated Hospital of Zunyi Medical University: Zunyi, CN

Employment
Source: Self-asserted source
Zeming Mo

Sichuan University West China Hospital: Chengdu, Sichuan, CN

Employment
Source: Self-asserted source
Zeming Mo

Works (8)

Comparing the difference of adverse events with HER2 inhibitors: a study of the FDA adverse event reporting system (FAERS)

Frontiers in Pharmacology
2024-01-24 | Journal article
Part of ISSN: 1663-9812
Contributors: Yiwen Bao; Jiaju Chen; Luting Duan; Fujue Wang; Han Lai; Zeming Mo; Weiliang Zhu
Source: Self-asserted source
Zeming Mo

Evaluation of cardiotoxicity of anthracycline‐containing chemotherapy regimens in patients with bone and soft tissue sarcomas: A study of the FDA adverse event reporting system joint single‐center real‐world experience

Cancer Medicine
2023-12 | Journal article
Contributors: Zeming Mo; Yaotiao Deng; Yiwen Bao; Jie Liu; Yu Jiang
Source: check_circle
Crossref

Association of NRAS mutations and tertiary lymphoid structure formation with clinical outcomes of adjuvant PD-1 inhibitors for acral melanoma

International Immunopharmacology
2023-11 | Journal article
Contributors: Zeming Mo; Jie Liu; Jinyan Zhang; Yaotiao Deng; Miao Xu; Yu Jiang
Source: check_circle
Crossref

Low-Dose Radiation Therapy Promotes Radiation Pneumonitis by Activating NLRP3 Inflammasome

International Journal of Radiation Oncology Biology Physics
2020 | Journal article
EID:

2-s2.0-85086711217

Part of ISBN:

1879355X 03603016

Contributors: Li, X.; Gong, Y.; Li, D.; Xiang, L.; Ou, Y.; Jiang, L.; Shu, P.; Liu, X.; Guo, F.; Qin, D. et al.
Source: Self-asserted source
Zeming Mo via Scopus - Elsevier

The construction of RORI targeting chimeric antigen receptor modified T cells and its killing effect for RORI- positive tumor cells

Journal of Sichuan University (Medical Science Edition)
2019 | Journal article
EID:

2-s2.0-85066133383

Part of ISBN:

1672173X

Contributors: Chen, Y.; Mo, Z.-M.; Qin, D.-Y.; Guo, F.-C.; Liao, X.-L.; Hu, M.; Chen, Q.; Wang, Y.-S.
Source: Self-asserted source
Zeming Mo via Scopus - Elsevier

The Multi-Purpose Tool of Tumor Immunotherapy: Gene-Engineered T Cells

Journal of Cancer
2017 | Journal article
Part of ISSN: 1837-9664
Source: Self-asserted source
Zeming Mo
grade
Preferred source (of 2)‎

Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors

Science China Life Sciences
2016 | Journal article
EID:

2-s2.0-84960408404

Part of ISBN:

16747305

Contributors: Zhang, B.-L.; Qin, D.-Y.; Mo, Z.-M.; Li, Y.; Wei, W.; Wang, Y.-S.; Wang, W.; Wei, Y.-Q.
Source: Self-asserted source
Zeming Mo via Scopus - Elsevier

Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis

Oral Oncology
2015 | Journal article
EID:

2-s2.0-84945470513

Part of ISBN:

18790593 13688375

Contributors: Zhang, B.; Mo, Z.; Du, W.; Wang, Y.; Liu, L.; Wei, Y.
Source: Self-asserted source
Zeming Mo via Scopus - Elsevier